Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Influence of patient character...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Influence of patient characteristics on Helicobacter pylori eradication with Vonoprazan: A subgroup analysis of the pHalcon‐HP trial

Influence of patient characteristics on Helicobacter pylori eradication with Vonoprazan: A subgroup analysis of the pHalcon‐HP trial

Bibliographic Details
Main Authors: William D Chey, Francis Mégraud, Loren Laine, Neila Smith, Eckhard Leifke, Barbara Hunt, Colin W Howden
Format: Article
Language:English
Published: Wiley 2024-11-01
Series:JGH Open
Subjects:
clinical trial
Helicobacter pylori
potassium competitive acid blockers
proton pump inhibitors
vonoprazan
Online Access:https://doi.org/10.1002/jgh3.70044
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://doi.org/10.1002/jgh3.70044

Similar Items

  • Vonoprazan-amoxicillin combination therapy for Helicobacter pylori eradication: an umbrella review of meta-analyses
    by: Saif Syed, et al.
    Published: (2024-11-01)
  • Role of Vonoprazan in Helicobacter pylori Eradication Therapy in Japan
    by: Mitsushige Sugimoto, et al.
    Published: (2019-01-01)
  • The efficacy and mechanism of vonoprazan-containing triple therapy in the eradication of Helicobacter pylori
    by: Zinan Zhang, et al.
    Published: (2023-05-01)
  • Efficacy and safety of bismuth quadruple regimens containing minocycline and vonoprazan for eradication of Helicobacter pylori: Real‐world evidence
    by: Qiyunna He, et al.
    Published: (2024-05-01)
  • Vonoprazan and high‐dose amoxicillin dual therapy for Helicobacter pylori first‐line eradication: A single‐arm, interventional study
    by: Soichiro Sue, et al.
    Published: (2023-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs